Lin S, Wang L, Han C, Dai Y, et al. Targeting HTR2B suppresses nonfunctioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Galphaq/PLC/PKCgamma/STAT3 axis. Neuro Oncol 2024;26:2010-2026.
PMID: 38989697